Epstein-Barr virus-associated lymphoproliferative disorder in a child undergoing therapy for localized rhabdomyosarcoma

Medical and Pediatric Oncology

Volumn 34, Issue 5, 2000, Pages 358-360

  Sung, Lillian ^a   Dix, David ^a   Allen, Upton ^a   Weitzman, Sheila ^a   Cutz, Ernest ^a   Malkin, David ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Chemotherapy; Epstein Barr virus; Immunosuppression; Lymphoproliferative disorder; Rhabdomyosarcoma

Indexed keywords

ACICLOVIR; ALPHA INTERFERON; AMPHOTERICIN B; CELL NUCLEUS ANTIGEN; CYCLOPHOSPHAMIDE; CYTOMEGALOVIRUS ANTIBODY; DACTINOMYCIN; DNA; EARLY ANTIGEN; ETOPOSIDE; FOSCARNET; GANCICLOVIR; IFOSFAMIDE; IMMUNOGLOBULIN G; VINCRISTINE; VIRUS CAPSID ANTIGEN; VIRUS RNA;

ARTICLE; BIOPSY; CASE REPORT; CHILD; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; EMBRYONAL RHABDOMYOSARCOMA; EPSTEIN BARR VIRUS; FEMALE; HUMAN; IN SITU HYBRIDIZATION; LYMPHOPROLIFERATIVE DISEASE; NEUTROPENIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS INFECTION;

CHILD, PRESCHOOL; FATAL OUTCOME; FEMALE; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOCOMPROMISED HOST; LYMPHOPROLIFERATIVE DISORDERS; OPPORTUNISTIC INFECTIONS; RHABDOMYOSARCOMA, EMBRYONAL; SKULL NEOPLASMS; TEMPORAL BONE; TUMOR VIRUS INFECTIONS;

EID: 0034111628     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-911X(200005)34:5<358::AID-MPO9>3.0.CO;2-K     Document Type: Article

References (10)

1. Seibel NL, Cossman J, Magrath IT. Lymphoproliferative disorders. In: Pizzo PA, Poplack DG, editors. Principles and practice of pediatric oncology, 2nd ed. Philadelphia: Lippincott; 1993. p 595-616.
2. Perkkio M, Riikonen P, Seuri R, Vornanen M. Successful treatment of monoclonal, aggressive Epstein-Barr virus-associated B-cell lymphoproliferative disorder in a child with acute lymphoblastic leukemia. Med Pediatr Oncol 1999;32:447-449.
3. Ho M, Jaffe R, Miller G, et al. The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children. Transplantation 1988;45:4:719-727.
4. Benkerrou M, Durandy A, Fischer A. Therapy for transplant-related lymphoproliferative diseases. Hematol Oncol Clin North Am 1993;7:2:467-475.
5. Hanto DW, Fizzera G, Gajl-Peczalska KJ, et al. Acyclovir therapy of Epstein-Barr virus-induced posttransplant lymphoproliferative diseases. Transplant Proc 1985;17:1:89-92.
6. Shapiro BS, Chauvenet A, McGuire W, et al. Treatment of B-cell lymphoproliferative disorders with interferon alfa and intravenous immunoglobulin. N Engl J Med 1988;318:1334.
7. Joncas JH, Russo P, Brochu P, et al. Epstein-Barr virus polymorphic B-cell lymphoma associated with leukemia and with congenital immunodeficiencies. J Clin Oncol 1990;8:378-384.
8. Mustafa MM, Winick NJ, Margraf LR. Epstein-Barr virus lymphoproliferative disorder in children with leukemia: case report and review of the literature. J Pediatr Hematol Oncol 1997;19: 77-81.
9. Look AT, Naegele RF, Callihan T, et al. Fatal Epstein-Barr virus infection in a child with acute lymphoblastic leukemia in remission. Cancer Res 1981;41:4280-4283.
10. Hardy C, Feusner J, Harada S, et al. Fatal Epstein-Barr virus-induced lymphoproliferation complicating acute lymphoblastic leukemia. J Pediatr 1984;105:64-77.